Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches

Acta Pharmaceutica

Volumn 54, Issue 4, 2004, Pages 301-317

  Mehdizadeh, Amir ^a,b   Toliate, Tayebe ^a   Rouini, Mohammad Reza ^a   Abashzadeh, Sharyar ^b   Dorkoosh, Farid ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Hakim Pharmaceutical Company   (Iran)

Author keywords

Drug release; Fentanyl; Patches; Transdermal drug delivery systems

Indexed keywords

ACRONAL; ADHESIVE AGENT; CARBOMER; ETHYL CELLULOSE; EUDRAGIT; FENTANYL; GLYCEROL; HYDROXYETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; PROPYLENE GLYCOL; SUCCINIC ACID;

ARTICLE; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; KINETICS; MODEL; TRANSDERMAL PATCH;

EID: 12444251154     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. W. B. Barry, Novel mechanism and devices to enable successful transdermal delivery, Eur. J. Pharm. Sci. 14 (2001) 101-114.
2. W. B. Barry, Is transdermal drug delivery research still important today? Drug Disc. Today 6 (2001) 967-971.
3. R. H. Guy, Current status and future prospects of transdermal drug delivery, Pharm. Res. 13 (1996) 1765-1769.
4. S. S. Davis and L. Illum, Drug delivery systems for challenging molecules, Int. J. Pharm. 176 (1998) 1-8.
5. nd ed., Marcel Dekker, New York 1992, pp. 301-380.
6. rd ed., Marcel Dekker, New York 1996, pp. 239-298.
7. R. Panchagnula, Transdermal delivery of drugs, Indian J. Pharm. 29 (1997) 140-156.
8. T. Higuchi, Physical chemical analysis of percutaneous absorption process from creams and ointments, J. Soc. Cosmet. Chem. 11 (1960) 85-93.
9. A. M. Hillery, A. W. Lloyd and J. Swarbrick, Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists, Taylor & Francis, New York 2001, pp. 207-235.
10. D. G. Maillard-Salin, P. Becourt and G. Couarraze, A study of the adhesive-skin interface: Correlation between adhesion and passage of a drug, Int. J. Pharm. 200 (2000) 121-126.
11. P. R. P. Verma and T. E. G. K. Murthy, Transdermal flubiprofen delivery using HPMC matrices: Design, in vitro and in vivo evaluation, Drug Dev. Ind. Pharm. 23 (1997) 633-638.
12. Formulation Technology Based on Eudragit® E 100 for Manufacturing of Transdermal Therapy Systems, Data sheet, Rohm GmbH, Darmstadt 2000.
13. A. Mehdizadeh, T. Toliyat, M. R. Rouini and S. Abashzadeh, A validated and compendial method for determination of drug release of fentanyl transdermal patches, American Association of Pharmaceutical Scientists Annual Meeting and Exposition, October 26-30, 2003, Salt Lake City 2003, Vol. 5, No. 4, Abstract W4011.
14. United States Pharmacopeia, 26, National Formulary 21, United States Pharmacopeial Convention, Rockville 2003, pp. 2161-2165.
15. nd ed., Van Nostrand Reinhold, New York 1989, pp. 38-60.
16. T. M. Goulding, Handbook of Adhesive Technology, Marcel Dekker, New York 1994, pp. 549-564.
17. M. Guyot and F. Fawaz, Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol, Int. J. Pharm. 204 (2000) 171-182.
18. N. A. Armstrong and K. C. James, Understanding Experimental Design and Interpretation in Pharmaceutics, Ellis Horwood, Chichester 1990, pp. 27-54.
19. T. Higuchi, Mechanism of sustained action medication: theorethical analysis of rate of solid drugs dispersed in solid matrices, J. Pharm. Sci. 52 (1963) 1145-1149.
20. M. E. Johnson, D. Blankschtein and R. Langer, Permeation of steroids through human skin, J. Pharm. Sci. 84 (1995) 1144-1146.
21. W. J. Roberts and K. B. Sloan, Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model, J. Pharm. Sci. 89 (2000) 1415-1431.
22. D. F. Stmatialis, H. H. M. Rolevink and G. H. Koops, Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions, J. Control. Rel. 81 (2002) 335-345.
23. P. Minghetti, F. Cilurzo and L. Montanari, Evaluation of adhesive properties of patches based on acrylic materials, Drug Dev. Ind. Pharm. 25 (1999) 1-6.
24. E. S. Park, S. J. Chang, Y. S. Rhee and S. C. Chi, Effects of adhesives and permeation enhancers on the skin permeation of captopril. Drug Dev. Ind. Pharm. 27 (2001) 975-980.